Cargando…

Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials

INTRODUCTION: Disease incidence differs between males and females for some infectious or inflammatory diseases. Sex-differences in immune responses to some vaccines have also been observed, mostly to viral vaccines in adults. Little evidence is available on whether sex-differences occur in response...

Descripción completa

Detalles Bibliográficos
Autores principales:	Voysey, Merryn, Pollard, Andrew J, Perera, Rafael, Fanshawe, Thomas R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985783/ https://www.ncbi.nlm.nih.gov/pubmed/27473951 http://dx.doi.org/10.1136/bmjopen-2016-011680

Ejemplares similares

Factors influencing women's attitudes towards antenatal vaccines, group B Streptococcus and clinical trial participation in pregnancy: an online survey
por: McQuaid, Fiona, et al.
Publicado: (2016)

Reactogenicity of COVID-19 Vaccines in Patients With a History of COVID-19 Infection: A Survey Conducted in Pakistan
por: Riyyan, Muhammad, et al.
Publicado: (2022)

Salmonella Vaccine Study in Oxford (SALVO) trial: protocol for an observer-participant blind randomised placebo-controlled trial of the iNTS-GMMA vaccine within a European cohort
por: Hanumunthadu, Brama, et al.
Publicado: (2023)

Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in healthy individuals: protocol for a systematic review and meta-analysis
por: Li, Mao, et al.
Publicado: (2021)

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults
por: Green, C A, et al.
Publicado: (2015)

Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol
por: Larivière, Ynke, et al.
Publicado: (2021)

Use of weighted multivariate estimates in trials of multi-serotype vaccines to simplify interpretation of treatment differences
por: Voysey, Merryn, et al.
Publicado: (2018)

Understanding paratyphoid infection: study protocol for the development of a human model of Salmonella enterica serovar Paratyphi A challenge in healthy adult volunteers
por: McCullagh, David, et al.
Publicado: (2015)

‘Reducing Delays In Vaccination’ (REDIVAC) trial: a protocol for a randomised controlled trial of a web-based, individually tailored, educational intervention to improve timeliness of infant vaccination
por: Dempsey, Amanda F, et al.
Publicado: (2019)

COVID-19 mRNA Vaccination, ABO Blood Type and the Severity of Self-Reported Reactogenicity in a Large Healthcare System: A Brief Report of a Cross-Sectional Study
por: Allan, Jennifer D, et al.
Publicado: (2021)

Accelerating clinical development of a live attenuated vaccine against Salmonella Paratyphi A (VASP): study protocol for an observer-participant-blind randomised control trial of a novel oral vaccine using a human challenge model of Salmonella Paratyphi A infection in healthy adult volunteers
por: McCann, Naina, et al.
Publicado: (2023)

HEV study protocol : design of a cluster-randomised, blinded trial to assess the safety, immunogenicity and effectiveness of the hepatitis E vaccine HEV 239 (Hecolin) in women of childbearing age in rural Bangladesh
por: Zaman, K, et al.
Publicado: (2020)

Methods for predicting vaccine immunogenicity and reactogenicity
por: Gonzalez-Dias, Patrícia, et al.
Publicado: (2019)

Computing threshold antibody levels of protection in vaccine clinical trials: An assessment of methodological bias
por: Voysey, Merryn, et al.
Publicado: (2018)

Social Data: An Underutilized Metric for Determining Participation in COVID-19 Vaccinations
por: McCarthy, Alec D, et al.
Publicado: (2021)

Determining the Optimal SARS-CoV-2 mRNA Vaccine Dosing Interval for Maximum Immunogenicity
por: Asamoah-Boaheng, Michael, et al.
Publicado: (2023)

Side effects of COVID-19 vaccines: a systematic review and meta-analysis protocol of randomised trials
por: Medeiros, Kleyton Santos, et al.
Publicado: (2022)

Impact of BCG revaccination on the response to unrelated vaccines in a Ugandan adolescent birth cohort: randomised controlled trial protocol C for the ‘POPulation differences in VACcine responses’ (POPVAC) programme
por: Zirimenya, Ludoviko, et al.
Publicado: (2021)

BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol for a randomised controlled trial (BRACE trial)
por: Pittet, Laure F, et al.
Publicado: (2021)

Self-reported Human Papillomavirus Vaccination and Vaccine Effectiveness Among Men Who Have Sex with Men: A Quantitative Bias Analysis
por: Chambers, Catharine, et al.
Publicado: (2023)

Effect of intensive treatment for schistosomiasis on immune responses to vaccines among rural Ugandan island adolescents: randomised controlled trial protocol A for the ‘POPulation differences in VACcine responses’ (POPVAC) programme
por: Nkurunungi, Gyaviira, et al.
Publicado: (2021)

Immunogenicity and Reactogenicity in Q Fever Vaccine Development
por: Fratzke, Alycia P., et al.
Publicado: (2022)

A Phase I study evaluating the safety and immunogenicity of MVA85A, a candidate TB vaccine, in HIV-infected adults
por: Minassian, Angela M, et al.
Publicado: (2011)

Effect of intermittent preventive treatment for malaria with dihydroartemisinin-piperaquine on immune responses to vaccines among rural Ugandan adolescents: randomised controlled trial protocol B for the ‘POPulation differences in VACcine responses’ (POPVAC) programme
por: Natukunda, Agnes, et al.
Publicado: (2021)

Immunogenicity and safety of mixed COVID-19 vaccine regimens in patients with immune-mediated inflammatory diseases: a single-centre prospective cohort study
por: Hitchon, Carol A, et al.
Publicado: (2023)

Using provider–parent strategies to improve influenza vaccination in children and adolescents with special risk medical conditions: a randomised controlled trial protocol
por: Tuckerman, Jane, et al.
Publicado: (2022)

B Part of It protocol: a cluster randomised controlled trial to assess the impact of 4CMenB vaccine on pharyngeal carriage of Neisseria meningitidis in adolescents
por: Marshall, Helen S, et al.
Publicado: (2018)

Immunogenicity and Reactogenicity of Coadministration of COVID-19 and Influenza Vaccines
por: Gonen, Tal, et al.
Publicado: (2023)

Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV
por: Motta, Edwiges, et al.
Publicado: (2023)

Early use of Antibiotics for at Risk CHildren with InfluEnza (ARCHIE): protocol for a double-blind, randomised, placebo-controlled trial
por: Wang, Kay, et al.
Publicado: (2018)

Adverse events following immunisation with four-component meningococcal serogroup B vaccine (4CMenB): interaction with co-administration of routine infant vaccines and risk of recurrence in European randomised controlled trials
por: Zafack, Joseline Guetsop, et al.
Publicado: (2019)

Timeliness of signal detection for adverse events following influenza vaccination in young children: a simulation case study
por: Jacoby, Peter, et al.
Publicado: (2020)

Predictors of hospitalization and severe disease due to breakthrough SARS‐CoV‐2 infection in fully vaccinated individuals
por: Johnson, Steven, et al.
Publicado: (2022)

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)
por: Yahav, Dafna, et al.
Publicado: (2021)

Protocol for a randomised controlled trial of continuous infusions of vancomycin to improve the attainment of target vancomycin levels in young infants: The VANC trial
por: Gwee, Amanda, et al.
Publicado: (2018)

Austerity, measles and mandatory vaccination: cross-regional analysis of vaccination in Italy 2000–14
por: Toffolutti, Veronica, et al.
Publicado: (2019)

Adolescent self-consent for vaccinations: protocol for a mixed methods systematic review
por: Fisher, Harriet, et al.
Publicado: (2018)

Awareness of the Malaria Vaccine in India
por: Singhal, Chinar, et al.
Publicado: (2022)

Vaccination in Kidney Transplant Candidates
por: Gajurel, Kiran, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b5nmu95oj269oje6gj769m3ipm